A QEEG Database Method for Predicting Pharmacotherapeutic Outcome in Refractory Major Depressive Disorders

This prospective, randomized, blinded, controlled study compared outcomes in chronic, refractory major depressive disorder (MDD) with and without physicians’ prescribing medications guided by electroencephalography-based medication outcome prediction. There were statistically significant differences between the two groups in pretreatment vs. treatment Hamilton Depression Scale and Beck Depression Inventory scores ( <.009) and Clinical Global Impression (CGI) scores ( = .02). Only one of six patients demonstrated clinical improvement with medication choice unguided by EEG data, compared to six of seven patients treated with EEG guidance. Pretreatment EEG data predicted medication response in this pilot study. PP

[1]  S C Suffin,et al.  Neurometric Subgroups in Attentional and Affective Disorders and Their Association with Pharmacotherapeutic Outcome , 1995, Clinical EEG.

[2]  M. Thase,et al.  Research issues in the study of difficult-to-treat depression , 2003, Biological Psychiatry.

[3]  R. Joffe.  Refractory depression: treatment strategies, with particular reference to the thyroid axis. , 1997, Journal of psychiatry & neuroscience : JPN.

[4]  C. Nemeroff,et al.  Lithium augmentation of antidepressants in treatment-refractory depression. , 1998, The Journal of clinical psychiatry.

[5]  D. Cantwell,et al.  Response to stimulant drug treatment in hyperactive children: Prediction from EEG and neurological findings , 1973, Journal of autism and childhood schizophrenia.

[6]  L. Judd.  The clinical course of unipolar major depressive disorders. , 1997, Archives of general psychiatry.

[7]  P. Rucci,et al.  Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders. , 1998, The Journal of clinical psychiatry.

[8]  L. Ginsberg,et al.  Topographical analysis of adolescent affective disorders. , 1996, The International journal of neuroscience.

[9]  W. Youden,et al.  Index for rating diagnostic tests , 1950, Cancer.

[10]  E. John,et al.  Quantitative Electroencephalography in OCD Patients Treated with Paroxetine , 2003, Clinical EEG.

[11]  Joffe Rt.  Refractory depression: treatment strategies, with particular reference to the thyroid axis. , 1997 .

[12]  H. Stassen,et al.  Suicide risk in patients with major depressive disorder. , 1999, The Journal of clinical psychiatry.

[13]  R. Shelton.  Treatment options for refractory depression. , 1999, The Journal of clinical psychiatry.

[14]  Y. Okubo,et al.  Electroencephalography in schizophrenic patients: Comparison between neuroleptic-naive state and after treatment , 1996, Biological Psychiatry.

[15]  A. Özge,et al.  Association of QEEG Findings with Clinical Characteristics of OCD: Evidence of Left Frontotemporal Dysfunction , 2002, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[16]  J. Nelson.  Treatment of antidepressant nonresponders: augmentation or switch? , 1998, The Journal of clinical psychiatry.

[17]  Robert J. Barry,et al.  Effects of stimulant medications on the EEG of girls with Attention-Deficit/Hyperactivity Disorder , 2002, Clinical Neurophysiology.

[18]  Rush Aj,et al.  FROM SCIENTIFIC KNOWLEDGE TO THE CLINICAL PRACTICE OF PSYCHOPHARMACOLOGY :CAN THE GAP BE BRIDGED ? , 1995 .

[19]  W M Herrmann,et al.  HZI systems for EEG parametrization and classification of psychotropic drugs. , 1979, Pharmakopsychiatrie, Neuro-Psychopharmakologie.

[20]  C. Shagass,et al.  Relationships between psychiatric diagnosis and some quantitative EEG variables. , 1982, Archives of general psychiatry.

[21]  A. Nierenberg,et al.  Dopaminergic agents and stimulants as antidepressant augmentation strategies. , 1998, The Journal of clinical psychiatry.

[22]  A. Rush,et al.  From scientific knowledge to the clinical practice of psychopharmacology: can the gap be bridged? , 1995, Psychopharmacology bulletin.

[23]  G. Winokur,et al.  All roads lead to depression: clinically homogeneous, etiologically heterogeneous. , 1997, Journal of affective disorders.

[24]  E. John,et al.  Quantitative electroencephalographic subtyping of obsessive-compulsive disorder , 1993, Psychiatry Research: Neuroimaging.

[25]  W. Alexander.  American psychiatric association. , 2008, P & T : a peer-reviewed journal for formulary management.

[26]  A. Rush,et al.  When at first you don't succeed: sequential strategies for antidepressant nonresponders. , 1997, The Journal of clinical psychiatry.

[27]  V. Knott,et al.  EEG power, frequency, asymmetry and coherence in male depression , 2001, Psychiatry Research: Neuroimaging.

[28]  E. John,et al.  Quantitative electrophysiological characteristics and subtyping of schizophrenia , 1994, Biological Psychiatry.

[29]  M. Thase,et al.  Treating antidepressant nonresponders with augmentation strategies: an overview. , 1998, The Journal of clinical psychiatry.